The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Immunosuppression and the Risk of Post-Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients
Open accessAbstract
The success of renal transplantation may be counterbalanced by serious adverse medical events. The effect of immunosuppression on the incidence of de novo neoplasms among kidney recipients should be monitored continuously. Using data from the Scientific Registry of Transplant Recipients, we studied the association of induction therapy by immunosuppression with antilymphocyte antibodies, with the development of de novo neoplasms. The study population included more than 41 000 recipients who received a cadaveric first kidney transplant after December 31, 1995, and were followed through February 28, 2002. Using Cox regression models, we estimated time to development of two types of malignancy: de novo solid tumors and post-transplant lymphoproliferative disorder (PTLD). We made adjustments for several patient demographic factors and comorbidities. Induction therapy was significantly associated with a higher relative risk (RR) of PTLD (RR = 1.78, p < 0.001), but not with a greater likelihood of de novo tumors (RR = 1.07, p = 0.42). Treatment with maintenance tacrolimus vs. cyclosporine showed a significantly different RR of developing de novo tumors for recipients with induction than for those not receiving induction (p = 0.024). These new estimates of the magnitude of malignancy risk associated with induction therapy may be useful for clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients
Opelz, G., & Henderson, R. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80084-4 · Cited by 648
Identifying the patient at risk for post‐transplant lymphoproliferative disorder
Cockfield, S. M. (2001) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2001.003002070.x · Cited by 273
Dharnidharka, V. R., Sullivan, E. K., Stablein, D. M., Tejani, A. H., & Harmon, W. E. (2001) · Transplantation · doi:10.1097/00007890-200104270-00010 · Cited by 222
Jain, A. B., Yee, L. D., Nalesnik, M. A., Youk, A., Marsh, G., Reyes, J., Zak, M., Rakela, J., Irish, W., & Fung, J. J. (1998) · Transplantation · doi:10.1097/00007890-199811150-00014 · Cited by 198
Posttransplantation de novo tumors in liver allograft recipients
Penn, I. (1996) · Liver Transplantation and Surgery · doi:10.1002/lt.500020109 · Cited by 134
Incidence and clinical course of de-novo malignancies in renal allograft recipients
Winkelhorst, J. T., Brokelman, W. J. A., Tiggeler, R. G. W. L., & Wobbes, T. (2001) · European Journal of Surgical Oncology · doi:10.1053/ejso.2001.1119 · Cited by 117
Cited by
Cancer after Kidney Transplantation in the United States
Kasiske, B. L., Snyder, J. J., Gilbertson, D. T., & Wang, C. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00450.x · Cited by 1,071
Clinical pancreatic islet transplantation
Shapiro, A. M. J., Pokrywczynska, M., & Ricordi, C. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.178 · Cited by 747
Taylor, A. L., Watson, C. J. E., & Bradley, J. A. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.03.012 · Cited by 445
Immunosuppressive Therapy and Malignancy in Organ Transplant Recipients: A Systematic Review
Gutierrez-Dalmau, A., & Campistol, J. M. (2007) · Drugs · doi:10.2165/00003495-200767080-00006 · Cited by 408
Metadata
- Authors
- Bustami, R. T., Ojo, A. O., Wolfe, R. A., Merion, R. M., Bennett, W. M., McDiarmid, S. V., Leichtman, A. B., Held, P. J., & Port, F. K.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 4
- Issue
- 1
- Pages
- 87-93
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2037926194
- Cited by
- 299
- References
- 6
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunosuppression and the Risk of Post-Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients. https://app.cochat.ai/papers/10.1046/j.1600-6135.2003.00274.x
- The paper
- Bustami, R. T., Ojo, A. O., Wolfe, R. A., Merion, R. M., Bennett, W. M., McDiarmid, S. V., Leichtman, A. B., Held, P. J., & Port, F. K. (2004). Immunosuppression and the Risk of Post-Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients. American Journal of Transplantation. https://doi.org/10.1046/j.1600-6135.2003.00274.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.